KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Leases (2016 - 2018)

Historic Current Leases for Gsk (GSK) over the last 3 years, with Q4 2018 value amounting to $30.9 million.

  • Gsk's Current Leases rose 113.35% to $30.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $30.9 million, marking a year-over-year increase of 113.35%. This contributed to the annual value of $32.1 million for FY2018, which is 818.11% up from last year.
  • Gsk's Current Leases amounted to $30.9 million in Q4 2018, which was up 113.35% from $30.5 million recorded in Q4 2017.
  • Over the past 5 years, Gsk's Current Leases peaked at $30.9 million during Q4 2018, and registered a low of $28.6 million during Q4 2016.
  • For the 3-year period, Gsk's Current Leases averaged around $30.0 million, with its median value being $30.5 million (2017).
  • As far as peak fluctuations go, Gsk's Current Leases soared by 679.23% in 2017, and later skyrocketed by 113.35% in 2018.
  • Quarter analysis of 3 years shows Gsk's Current Leases stood at $28.6 million in 2016, then grew by 6.79% to $30.5 million in 2017, then rose by 1.13% to $30.9 million in 2018.
  • Its Current Leases was $30.9 million in Q4 2018, compared to $30.5 million in Q4 2017 and $28.6 million in Q4 2016.